Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin Foa

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Haematologica|September 10, 2002
Fludarabine, ara-C, novantrone and dexamethasone (FAND) in previously treated chronic lymphocytic leukemia patientsFrancesca R Mauro, Robin Foa, Giovanna Meloni, et al.
The Journal of Experimental Medicine|January 7, 2004
Gene expression profiling of hairy cell leukemia reveals a phenotype related to memory B cells with altered expression of chemokine and adhesion receptorsKatia Basso, Arcangelo Liso, Enrico Tiacci, et al.
Leukemia & Lymphoma|July 21, 2005
A gender-based score system predicts the clinical outcome of patients with early B-cell chronic lymphocytic leukemiaStefano Molica, Francesca R Mauro, Vincenzo Callea, et al.
Blood|May 31, 2002
Human acute stem cell leukemia with multilineage differentiation potential via cascade activation of growth factor receptorsUgo Testa, Giovanni F Torelli, Roberta Riccioni, et al.
Leukemia & Lymphoma|April 7, 2009
Hemorrhagic complications in patients with advanced hematological malignancies followed at home: an Italian experienceClaudio Cartoni, Pasquale Niscola, Massimo Breccia, et al.
Annals of Hematology|June 29, 2018
Prolonged treatment with arsenic trioxide (ATO) and all-trans-retinoic acid (ATRA) for relapsed acute promyelocytic leukemia previously treated with ATRA and chemotherapyLaura Cicconi, Massimo Breccia, Luca Franceschini, et al.
European Journal of Haematology|December 27, 2019
Blinatumomab vs historic standard-of-care treatment for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukaemiaNicola Gökbuget, Hervé Dombret, Sebastian Giebel, et al.
The Journal of Experimental Medicine|August 18, 2004
Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemiaBradley T Messmer, Emilia Albesiano, Dimitar G Efremov, et al.
Blood|May 10, 2011
PTPN2 negatively regulates oncogenic JAK1 in T-cell acute lymphoblastic leukemiaMaria Kleppe, Jean Soulier, Vahid Asnafi, et al.
Blood|June 7, 2003
Clinico-biologic features and treatment outcome of adult pro-B-ALL patients enrolled in the GIMEMA 0496 study: absence of the ALL1/AF4 and of the BCR/ABL fusion genes correlates with a significantly better clinical outcomeGiuseppe Cimino, Loredana Elia, Marco Mancini, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Haematologica|September 10, 2002
Fludarabine, ara-C, novantrone and dexamethasone (FAND) in previously treated chronic lymphocytic leukemia patientsFrancesca R Mauro, Robin Foa, Giovanna Meloni, et al.
The Journal of Experimental Medicine|January 7, 2004
Gene expression profiling of hairy cell leukemia reveals a phenotype related to memory B cells with altered expression of chemokine and adhesion receptorsKatia Basso, Arcangelo Liso, Enrico Tiacci, et al.
Leukemia & Lymphoma|July 21, 2005
A gender-based score system predicts the clinical outcome of patients with early B-cell chronic lymphocytic leukemiaStefano Molica, Francesca R Mauro, Vincenzo Callea, et al.
Blood|May 31, 2002
Human acute stem cell leukemia with multilineage differentiation potential via cascade activation of growth factor receptorsUgo Testa, Giovanni F Torelli, Roberta Riccioni, et al.
Leukemia & Lymphoma|April 7, 2009
Hemorrhagic complications in patients with advanced hematological malignancies followed at home: an Italian experienceClaudio Cartoni, Pasquale Niscola, Massimo Breccia, et al.
Annals of Hematology|June 29, 2018
Prolonged treatment with arsenic trioxide (ATO) and all-trans-retinoic acid (ATRA) for relapsed acute promyelocytic leukemia previously treated with ATRA and chemotherapyLaura Cicconi, Massimo Breccia, Luca Franceschini, et al.
European Journal of Haematology|December 27, 2019
Blinatumomab vs historic standard-of-care treatment for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukaemiaNicola Gökbuget, Hervé Dombret, Sebastian Giebel, et al.
The Journal of Experimental Medicine|August 18, 2004
Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemiaBradley T Messmer, Emilia Albesiano, Dimitar G Efremov, et al.
Blood|May 10, 2011
PTPN2 negatively regulates oncogenic JAK1 in T-cell acute lymphoblastic leukemiaMaria Kleppe, Jean Soulier, Vahid Asnafi, et al.
Blood|June 7, 2003
Clinico-biologic features and treatment outcome of adult pro-B-ALL patients enrolled in the GIMEMA 0496 study: absence of the ALL1/AF4 and of the BCR/ABL fusion genes correlates with a significantly better clinical outcomeGiuseppe Cimino, Loredana Elia, Marco Mancini, et al.
Pageof 5